BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.785
-0.215 (-5.37%)
Feb 27, 2026, 12:25 PM EST - Market open
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $28.83 million as of February 27, 2026. Its market cap has increased by 185.45% in one year.
Market Cap
28.83M
Enterprise Value
17.76M
1-Year Change
185.45%
Ranking
Category
Stock Price
$3.79
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has increased from $26.00M to $28.83M, an increase of 10.89%. That is a compound annual growth rate of 2.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 7.50M | -44.03% |
| Dec 31, 2025 | 13.40M | -46.40% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evaxion | 28.11M |
| IGC Pharma | 27.80M |
| Hyperion DeFi | 27.04M |
| Lixte Biotechnology Holdings | 26.49M |
| Boundless Bio | 26.19M |
| Marker Therapeutics | 25.84M |
| Cue Biopharma | 25.84M |
| Reviva Pharmaceuticals Holdings | 25.77M |